abstract |
The present invention relates to antibodies against type 2 tumor necrosis factor receptor (TN-R2). More particularly, the invention concerns monoclonal antibodies against human TN-R2 which mimic the T-cell proliferation stimulating activity of TN. The use of such antibodies for the stimulation of human T-cell proliferation is encompassed by the present invention. |